NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJonathan Javitt - Founder, Chairman and CEOMichael Abrams - CFOPatrick R. Trucchio - Managing Director of Equity ResearchConference Call ParticipantsEdward Moon - AnalystThomas Shrader - Managing Director and Senior Biotechnology Equity Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 Results Conference Call. At this time, all lines are in listen-only ...

NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJonathan Javitt - Founder, Chairman and CEOMichael Abrams - CFOPatrick R. Trucchio - Managing Director of Equity ResearchConference Call ParticipantsEdward Moon - AnalystThomas Shrader - Managing Director and Senior Biotechnology Equity Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 results conference call. At this time, all lines are in listen-only ...

NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Speaker3Morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, March 24, 2026. I would now like to turn the ...